Literature DB >> 2491691

The hypnozoite and malarial relapse.

W A Krotoski.   

Abstract

As described above, perhaps the most compelling arguments against the cyclic schizogony (Shortt-Garnham) hypothesis of malarial relapse have been (1) its inability to explain the disparate relapse patterns of P. vivax strains as they occur in nature, and (2) the dearth of concrete evidence for its support. The hypnozoite theory, in contrast, both provides an explanation for the variety of observed relapse patterns, and has direct morphologic and time-related, quantitative evidence for its support. Moreover, it provides a potential, unifying framework for the development of relapsing malaria from the time of introduction of sporozoites onward, taking as controlling factors, both the survival of the parasite and ecological interactions within its natural environment. It also suggests the possibility of an improved taxonomic classification, one based on whether or not the hypnozoite stage exists in a given species. Finally, Figure 6 presents a composite of relapse data pertinent to a number of strain groups of P. vivax, in comparison with a generalized, nonrelapsing species, schematically depicted within the framework of the hypnozoite theory. Thus, no hypnozoites are shown to result from sporozoites of the nonrelapsing species at one extreme, whereas no sporozoites undergoing immediate schizogony (i.e. without dormancy) are found at the other, the "lost" P. vivax strain of Nicolaiev. In between, varying proportions of sporozoites are depicted as producing hypnozoites, which exhibit varying periods of dormancy, ranging from less than 1 month (within the wide complement of the "tropical" strains) to approximately 21 months or more for the "northern" strains, before activation to schizogony and resultant relapse at the observed intervals. Although the actual proportions of each sporozoite/hypnozoite type within the strains depicted are unknown, a single, successful sporozoite can yield a parasitemic relapse--their distribution among the major strain groupings appears reasonably distinct, and, to some extent, defines each grouping. The sequences of sporozoite to pre-erythrocytic schizont, to merozoite release, to erythrocyte, as seen in nonrelapsing malarias and early primary parasitemias, versus sporozoite to hypnozoite, to pre-erythrocytic schizont, to erythrocyte, as seen in relapses, are easily inferred from this summary of observed relapses. It is difficult to see how these observed phenomena can be satisfactorily explained by a cyclic schizogony mechanism. It must be emphasized, nevertheless, that additional work with other relapsing and nonrelapsing species is necessary in order to establish the concept fully, and to determine the molecular mechanisms for dormancy and activation of hypnozoites.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2491691

Source DB:  PubMed          Journal:  Prog Clin Parasitol        ISSN: 1062-0338


  29 in total

Review 1.  Resistance to therapies for infection by Plasmodium vivax.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

2.  Malarial liver parasites awaken in culture.

Authors:  John W Barnwell; Mary R Galinski
Journal:  Nat Med       Date:  2014-03       Impact factor: 53.440

3.  Epidemiologic characteristics of malaria in non-malarious area, Jeollabuk-do, Korea in 2000.

Authors:  M B Kim
Journal:  Korean J Parasitol       Date:  2001-09       Impact factor: 1.341

4.  Fy(a)/Fy(b) antigen polymorphism in human erythrocyte Duffy antigen affects susceptibility to Plasmodium vivax malaria.

Authors:  Christopher L King; John H Adams; Jia Xianli; Brian T Grimberg; Amy M McHenry; Lior J Greenberg; Asim Siddiqui; Rosalind E Howes; Monica da Silva-Nunes; Marcelo U Ferreira; Peter A Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

Review 5.  Red blood cell polymorphism and susceptibility to Plasmodium vivax.

Authors:  Peter A Zimmerman; Marcelo U Ferreira; Rosalind E Howes; Odile Mercereau-Puijalon
Journal:  Adv Parasitol       Date:  2013       Impact factor: 3.870

Review 6.  American canine hepatozoonosis.

Authors:  S A Ewing; R J Panciera
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

7.  Comparative genomics of the neglected human malaria parasite Plasmodium vivax.

Authors:  Jane M Carlton; John H Adams; Joana C Silva; Shelby L Bidwell; Hernan Lorenzi; Elisabet Caler; Jonathan Crabtree; Samuel V Angiuoli; Emilio F Merino; Paolo Amedeo; Qin Cheng; Richard M R Coulson; Brendan S Crabb; Hernando A Del Portillo; Kobby Essien; Tamara V Feldblyum; Carmen Fernandez-Becerra; Paul R Gilson; Amy H Gueye; Xiang Guo; Simon Kang'a; Taco W A Kooij; Michael Korsinczky; Esmeralda V-S Meyer; Vish Nene; Ian Paulsen; Owen White; Stuart A Ralph; Qinghu Ren; Tobias J Sargeant; Steven L Salzberg; Christian J Stoeckert; Steven A Sullivan; Marcio M Yamamoto; Stephen L Hoffman; Jennifer R Wortman; Malcolm J Gardner; Mary R Galinski; John W Barnwell; Claire M Fraser-Liggett
Journal:  Nature       Date:  2008-10-09       Impact factor: 49.962

Review 8.  The hypnozoite and relapse in primate malaria.

Authors:  F B Cogswell
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

9.  Naturally acquired inhibitory antibodies to Plasmodium vivax Duffy binding protein are short-lived and allele-specific following a single malaria infection.

Authors:  I P Ceravolo; B A M Sanchez; T N Sousa; B M Guerra; I S Soares; E M Braga; A M McHenry; J H Adams; C F A Brito; L H Carvalho
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

Review 10.  Plasmodium vivax: who cares?

Authors:  Mary R Galinski; John W Barnwell
Journal:  Malar J       Date:  2008-12-11       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.